Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J HUG

Showing results (51-60 of 196) with videos related to

Pageof 20
Sort By:
Molecular Metabolism|July 21, 2022
Cardiovascular protection by SGLT2 inhibitors - Do anti-inflammatory mechanisms play a role?Asmaa Elrakaybi, Katharina Laubner, Qian Zhou, et al.
Medizinische Klinik (Munich, Germany : 1983)|July 1, 1994
[Coronary dilatation after intracoronary administration of SIN-1 and intravenous molsidomine administration]J Hug, G Hasenfuss, H Wollschläger, et al.
The Journal of Biological Chemistry|August 31, 2001
The small conductance K+ channel, KCNQ1: expression, function, and subunit composition in murine tracheaF Grahammer, R Warth, J Barhanin, et al.
Pflugers Archiv : European Journal of Physiology|January 29, 2000
Evidence for Na+/Ca2+ exchange in the rectal gland of Squalus acanthiasM Bleich, M J Hug, D Heitzmann, et al.
Journal of Clinical Apheresis|March 12, 2010
Controlled application and removal of liposomal therapeutics: effective elimination of pegylated liposomal doxorubicin by double-filtration plasmapheresis in vitroGerhard Pütz, Oliver Schmah, Jürgen Eckes, et al.
Environmental Science & Technology|May 11, 2006
Iron-mediated oxidation of antimony(III) by oxygen and hydrogen peroxide compared to arsenic(III) oxidationAnn-Kathrin Leuz, Stephan J Hug, Bernhard Wehrli, et al.
Medical Hypotheses|January 17, 2009
Controlled application and scheduled removal of nanoparticle based chemotherapeutics (CARL) will reduce dose limiting adverse events in anticancer chemotherapyGerhard Pütz, Oliver Schmah, Jürgen Eckes, et al.
Zeitschrift Fur Gerontologie Und Geriatrie|February 18, 2017
[Compression therapy of chronic leg ulcers : Practical aspects]J Dissemond, K Protz, J Hug, et al.
International Journal of Clinical Pharmacy|October 30, 2025
Medication safety in patients with hepatic disease: proof of concept of a new approach to screen for patients at risk-a retrospective evaluation utilizing electronic prescribing systemsDorothea Strobach, Alina Grebe, Julian Steinbrech, et al.
The Journal of Biological Chemistry|May 9, 2000
Protein kinase A associates with cystic fibrosis transmembrane conductance regulator via an interaction with ezrinF Sun, M J Hug, N A Bradbury, et al.
Pageof 20

Showing results (51-60 of 196) with videos related to

Sort By:
Pageof 20
Molecular Metabolism|July 21, 2022
Cardiovascular protection by SGLT2 inhibitors - Do anti-inflammatory mechanisms play a role?Asmaa Elrakaybi, Katharina Laubner, Qian Zhou, et al.
Medizinische Klinik (Munich, Germany : 1983)|July 1, 1994
[Coronary dilatation after intracoronary administration of SIN-1 and intravenous molsidomine administration]J Hug, G Hasenfuss, H Wollschläger, et al.
The Journal of Biological Chemistry|August 31, 2001
The small conductance K+ channel, KCNQ1: expression, function, and subunit composition in murine tracheaF Grahammer, R Warth, J Barhanin, et al.
Pflugers Archiv : European Journal of Physiology|January 29, 2000
Evidence for Na+/Ca2+ exchange in the rectal gland of Squalus acanthiasM Bleich, M J Hug, D Heitzmann, et al.
Journal of Clinical Apheresis|March 12, 2010
Controlled application and removal of liposomal therapeutics: effective elimination of pegylated liposomal doxorubicin by double-filtration plasmapheresis in vitroGerhard Pütz, Oliver Schmah, Jürgen Eckes, et al.
Environmental Science & Technology|May 11, 2006
Iron-mediated oxidation of antimony(III) by oxygen and hydrogen peroxide compared to arsenic(III) oxidationAnn-Kathrin Leuz, Stephan J Hug, Bernhard Wehrli, et al.
Medical Hypotheses|January 17, 2009
Controlled application and scheduled removal of nanoparticle based chemotherapeutics (CARL) will reduce dose limiting adverse events in anticancer chemotherapyGerhard Pütz, Oliver Schmah, Jürgen Eckes, et al.
Zeitschrift Fur Gerontologie Und Geriatrie|February 18, 2017
[Compression therapy of chronic leg ulcers : Practical aspects]J Dissemond, K Protz, J Hug, et al.
International Journal of Clinical Pharmacy|October 30, 2025
Medication safety in patients with hepatic disease: proof of concept of a new approach to screen for patients at risk-a retrospective evaluation utilizing electronic prescribing systemsDorothea Strobach, Alina Grebe, Julian Steinbrech, et al.
The Journal of Biological Chemistry|May 9, 2000
Protein kinase A associates with cystic fibrosis transmembrane conductance regulator via an interaction with ezrinF Sun, M J Hug, N A Bradbury, et al.
Pageof 20